Products for Research Use Only
RegisterLogin

Barecetamab

CAT: 0804-HY-P99461-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99461-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2275727-74-5
UNSPSC Description
Barecetamab (ISU-104) is a fully human anti-ErbB3 monoclonal antibody. Barecetamab can be used for the research of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)[1].
Target Antigen
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/barecetamab.html
Purity
97.96
Solubility
H2O
Smiles
[Barecetamab]
References & Citations
[1]Kim SB, et, al. 887P Final results and biomarker analysis from a phase I dose-expansion (part II) study of ISU104 (barecetamab; a novel anti-ErbB3) monotherapy or in combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). VOLUME 32, SUPPLEMENT 5, S797, SEPTEMBER 01, 2021.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Clinical Information
Phase 1

Alternative Products

CatalogName
MBS5818843Barecetamab
E55B0772Barecetamab (Reference antibody)
HB116066-01Research Grade Barecetamab
ICH5373-1mgBarecetamab Biosimilar - Research Grade
047759ERBB3/HER3 (barecetamab) discontinued
21-889Barecetamab - Research Grade Biosimilar
F1415-1Anti-ERBB3/HER3 Antibody (Barecetamab)
RA0230-01Barecetamab (Biosimilar Reference Antibody) (ERBB3)
A135456Barecetamab Biosimilar (Monoclonal, IgG1-Lambda)
M00539-7Anti-ERBB3 / HER3 Reference Antibody (barecetamab)

Popular Products